Omeros (OMER) EBITDA Margin Growth (3y) (2013 - 2022)
Omeros (OMER) EBITDA Margin Growth (3y) (2013 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,942.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -623.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Omeros | 739.31 Mn | 739.31 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -33,570.00 |
| Mar 31, 2022 | -41,261.00 |
| Dec 31, 2021 | 13,759.00 |
| Sep 30, 2021 | 63,640.00 |
| Jun 30, 2021 | 169,173.00 |
| Mar 31, 2021 | 152,860.00 |
| Dec 31, 2020 | -21,544.00 |
| Sep 30, 2020 | -7,378.00 |
| Jun 30, 2020 | -13,497.00 |
| Mar 31, 2020 | 322.00 |
| Dec 31, 2019 | 2,095.00 |
| Sep 30, 2019 | 6,945.00 |
| Jun 30, 2019 | 7,434.00 |
| Mar 31, 2019 | 17,385.00 |
| Dec 31, 2018 | 18,635.00 |
| Sep 30, 2018 | -17,690.00 |
| Jun 30, 2018 | -134,897.00 |
| Mar 31, 2018 | 287,749.00 |
| Dec 31, 2017 | 1.10 Mn |
| Sep 30, 2017 | 798,201.00 |